XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements Of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
REVENUE (Note 15) $ 138,194 $ 133,968 $ 418,176 $ 394,822
EXPENSE        
Cost of goods sold, IT processing, servicing and support 107,854 105,299 329,610 314,651
Selling, general and administration 23,124 24,547 67,146 70,995
Depreciation and amortization 5,791 5,975 17,460 17,892
Transaction costs related to Adumo acquisition (Note 20) 631 0 665 0
OPERATING INCOME (LOSS) 794 (1,853) 3,295 (8,716)
REVERSAL OF ALLOWANCE FOR DOUBTFUL EMI DEBT RECEIVABLE 0 0 250 0
(LOSS) GAIN ON DISPOSAL OF EQUITY-ACCOUNTED INVESTMENT (Note 5) 0 (329) 0 (193)
INTEREST INCOME 628 469 1,562 1,269
INTEREST EXPENSE 4,581 4,984 14,312 13,408
LOSS BEFORE INCOME TAX EXPENSE (BENEFIT) (3,159) (6,697) (9,205) (21,048)
INCOME TAX EXPENSE (BENEFIT) (Note 18) 931 (860) 1,881 (465)
NET LOSS BEFORE EARNINGS (LOSS) FROM EQUITY-ACCOUNTED INVESTMENTS (4,090) (5,837) (11,086) (20,583)
EARNINGS (LOSS) FROM EQUITY-ACCOUNTED INVESTMENTS (Note 5) 43 17 (1,319) (2,582)
NET LOSS ATTRIBUTABLE TO LESAKA $ (4,047) $ (5,820) $ (12,405) $ (23,165)
Net loss per share, in United States dollars (Note 13):        
Basic loss attributable to Lesaka shareholders $ (0.06) $ (0.09) $ (0.20) $ (0.37)
Diluted loss attributable to Lesaka shareholders $ (0.06) $ (0.09) $ (0.20) $ (0.37)